Maurizio Federico

Title: Maurizio Federico: Innovator in HIV Research

Introduction

Maurizio Federico is a prominent inventor based in Rome, Italy. He has made significant contributions to the field of HIV research, holding 2 patents that focus on innovative methods to combat HIV infection. His work is characterized by a deep understanding of molecular biology and virology.

Latest Patents

Federico's latest patents include groundbreaking inventions. The first patent is titled "Compositions comprising fusion polypeptides HIV-Nef and NGF, and methods of using the same." This invention involves a conjugate that includes a sequence from the human low affinity Nerve Growth Factor receptor (LNGFR) and a mutant HIV Nef sequence. The second patent, "Composition and method of imparting resistivity to HIV superinfection to cells," describes a unique HIV type 1 provirus cloned from a nonproducer, chronically-infected cell clone. This invention provides a method to confer resistance to HIV superinfection in human cells without affecting CD4 receptor exposure.

Career Highlights

Throughout his career, Maurizio Federico has worked with esteemed institutions, including the Istituto Superiore Di Sanita. His research has focused on developing innovative strategies to protect human cells from HIV infection, showcasing his commitment to advancing medical science.

Collaborations

Federico has collaborated with notable colleagues such as Paola Verani and Fulvio Mavilio. These partnerships have contributed to the success of his research and the development of his patents.

Conclusion

Maurizio Federico's contributions to HIV research through his patents and collaborations highlight his role as an innovator in the field. His work continues to inspire advancements in the fight against HIV infection.